Prevalence of tracheal collapse in an emphysema cohort as measured with end-expiration CT.

Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA 90024-2926, USA.
Academic radiology (Impact Factor: 2.09). 02/2009; 16(1):46-53. DOI: 10.1016/j.acra.2008.05.020
Source: PubMed

ABSTRACT To retrospectively investigate the prevalence of tracheal collapse in an emphysema cohort. The occurrence of a large degree of tracheal collapse may have important implications for the clinical management of respiratory symptoms and air trapping in patients with emphysema.
Paired full-inspiratory and end-expiratory thin-section volumetric computed tomographic scans were available for 1071 long-term smokers with clinically and physiologically confirmed emphysema. The percentage reduction in the cross-sectional tracheal luminal area from full-inspiration to end-expiration was automatically computed at 2.5-mm intervals along the centerline of the trachea using customized software.
Maximal tracheal collapse did not follow a normal distribution in the emphysema cohort (P < .0001, skewness/kurtosis tests for normality); the median collapse was 18% (intraquartile range, 11%-30%). Statistically significant differences were found in the distribution of maximal collapse by gender (P < .005, Wilcoxon rank sum test). Overall, 10.5% of men and 17.1% of women showed evidence of tracheomalacia on the basis of the criterion of a reduction of 50% or greater in cross-sectional tracheal luminal area at end-expiration.
This study offers insights into the prevalence of tracheal collapse in a cohort of patients with emphysema; future work is needed to determine the possible relationship between tracheal collapse and air trapping in subjects with emphysema.


Available from: Jonathan Goldin, Mar 31, 2015

Click to see the full-text of:

Article: Prevalence of tracheal collapse in an emphysema cohort as measured with end-expiration CT.

2.26 MB

See full-text
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the range of tracheal collapse at end-expiration among chronic obstructive pulmonary disease (COPD) patients and to compare the extent of tracheal collapse between static end-expiratory and dynamic forced-expiratory multidetector-row computed tomography (MDCT). After institutional review board approval and obtaining informed consent, 67 patients meeting the National Heart, Lung, and Blood Institute (NHLBI)/World Health Organization (WHO) Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for COPD were sequentially imaged using a 64-detector-row CT machine at end-inspiration, during forced expiration, and at end-expiration. Standardized respiratory coaching and spirometric monitoring were employed. Mean percentage tracheal collapse at end-expiration and forced expiration were compared using correlation analysis, and the power of end-expiratory cross-sectional area to predict excessive forced-expiratory tracheal collapse was computed following construction of receiver operating characteristic (ROC) curves. Mean percentage expiratory collapse among COPD patients was 17 ± 18% at end-expiration compared to 62 ± 16% during forced expiration. Over the observed range of end-expiratory tracheal collapse (approximately 10-50%), the positive predictive value of end-expiratory collapse to predict excessive (≥80%) forced expiratory tracheal collapse was <0.3. COPD patients demonstrate a wide range of end-expiratory tracheal collapse. The magnitude of static end-expiratory tracheal collapse does not predict excessive dynamic expiratory tracheal collapse.
    Clinical Radiology 12/2013; DOI:10.1016/j.crad.2013.11.003 · 1.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Severe tracheomalacia (STM) is being increasingly recognized as a cause for respiratory failure in the ICU. The diagnosis is often overlooked as chest radiography appears normal and the role of invasive diagnostic testing for this diagnosis is not well described in the ICU setting. The prevalence and risk factors for STM are not known and a CT based diagnostic criteria for ventilated patients are not well studied. METHODS: Patients admitted between January, 2008 and December, 2010 with respiratory failure who failed ventilator discontinuation or required re-intubation were screened for the presence of any tracheal collapse utilizing prior chest CT. Bronchoscopically confirmed cases were compared with age and sex matched controls to identify risk factors. RESULTS: Twenty-five subjects were identified as having STM, represented 0.7% of ICU admissions and 1.6% of patients with respiratory failure. The mean length of ICU stay was significantly longer in STM (30 days, CI 20-40) compared to controls (4*4 days, CI 3*6-5). Obesity (OR 1.25, 1.02-1.54)) and gastro-esophageal reflux (OR 31, 1.7- 586) were associated with increased risk for STM. The pre-intubation PaCO₂ (68 mmHg, CI 57-79) was significantly higher in STM compared to controls (38mm, CI 38-41). The distal tracheal antero-posterior (AP) diameter (2.80 mm; CI 2.15-3.46) was significantly lower in STM. A ROC analysis showed the distal tracheal AP diameter <7 mm to be the optimal cutoff measurement to diagnose STM. CONCLUSION: STM was associated with prolonged ICU stay. The distal tracheal AP diameter <7 mm on a non-intubated CT chest was suggestive of STM that required a confirmatory bronchoscopy. Gastro-esophageal reflux disease and obesity were potential risk factors.
    Respiratory care 08/2012; DOI:10.4187/respcare.01866 · 1.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tracheobronchomalacia (TBM) and hyperdynamic airway collapse (HDAC) can be debilitating diseases associated with decreased functional capacity and poor quality of life, although there is no standard definition of this complex condition, and there are numerous terms used to describe it. The diverse etiology associated with TBM and HDAC can obscure and delay an accurate diagnosis for years. A thorough medical history is important in understanding possible causes and in guiding diagnostic testing. Medical history may also suggest what treatments may be most beneficial.
    Immunology and allergy clinics of North America 02/2013; 33(1):23-34. DOI:10.1016/j.iac.2012.10.005 · 3.18 Impact Factor